2,673
Views
10
CrossRef citations to date
0
Altmetric
Brief Report

Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors

, , , , , , , , & show all
Pages 72-77 | Received 24 Jun 2018, Accepted 16 Oct 2018, Published online: 09 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ivan V Pozhidaev, Anastasiia S Boiko, Anton J M Loonen, Diana Z Paderina, Olga Yu Fedorenko, Gennadiy Tenin, Elena G Kornetova, Arkadiy V Semke, Nikolay A Bokhan, Bob Wilffert & Svetlana A Ivanova. (2020) Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia. The Application of Clinical Genetics 13, pages 97-105.
Read now

Articles from other publishers (9)

Diana Z. Paderina, Anastasiia S. Boiko, Ivan V. Pozhidaev, Irina A. Mednova, Anastasia A. Goncharova, Anna V. Bocharova, Olga Yu. Fedorenko, Elena G. Kornetova, Arkadiy V. Semke, Nikolay A. Bokhan, Anton J. M. Loonen & Svetlana A. Ivanova. (2022) The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia. Genes 13:8, pages 1312.
Crossref
Evangelia Eirini Tsermpini, Sara Redenšek & Vita Dolžan. (2022) Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies. Frontiers in Pharmacology 12.
Crossref
Evangelia Eirini Tsermpini, Tea Terzi, Blanka Kores Plesničar & Vita Dolžan. 2022. Psychiatric Genomics. Psychiatric Genomics 161 188 .
Maria J. Arranz, Juliana Salazar & Marta H. Hernández. (2021) Pharmacogenetics of antipsychotics: Clinical utility and implementation. Behavioural Brain Research 401, pages 113058.
Crossref
E. E. Vaiman, N. A. Shnayder, N. G. Neznanov & R. F. Nasyrova. (2020) Candidate genes involved in the development of antipsychotic-induced tardive dyskinesia in patients with schizophrenia. Neuromuscular Diseases 10:3, pages 10-26.
Crossref
Ivan V. Pozhidaev, Diana Z. Paderina, Olga Yu. Fedorenko, Elena G. Kornetova, Arkadiy V. Semke, Anton J. M. Loonen, Nikolay A. Bokhan, Bob Wilffert & Svetlana A. Ivanova. (2020) 5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia. Frontiers in Molecular Neuroscience 13.
Crossref
E. E. Vayman, N. A. Shnayder, N. G. Neznanov & R. F. Nasyrova. (2020) Pathophysiological mechanisms underlying antipsychotic-induced tardive dyskinesia. Bulletin of Siberian Medicine 18:4, pages 169-184.
Crossref
Anton JM Loonen, Bob Wilffert & Svetlana A Ivanova. (2019) Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia. Pharmacogenomics 20:17, pages 1199-1223.
Crossref
Maikel Kronbauer, Vinicia Garzela Metz, Karine Roversi, Laura H. Milanesi, Domenika Rubert Rossato, Raquel Cristine da Silva Barcelos & Marilise E. Burger. (2019) Influence of magnesium supplementation and L-type calcium channel blocker on haloperidol-induced movement disturbances. Behavioural Brain Research 374, pages 112119.
Crossref